Upadacitinib Phase 3 Trials Identify Psychological and Functional Benefits of Ambitious Treatment Targets in AD

Summary: New research shows that when treating severe eczema (atopic dermatitis), aiming for almost completely clear skin and zero itch is worth the extra effort. Patients who hit these high targets with treatments like upadacitinib saw huge improvements in their daily lives. They slept better, felt less anxious and depressed, and had much less skin pain. In fact, 82% of patients who reached these top goals were extremely satisfied with their treatment, compared to those who only saw moderate improvement. The main takeaway? Don't settle for "good enough" when it comes to treating your skin.

For more details, see rssapp-dermatologytimes-com at dermatologytimes.com/view/upadacitinib-phase-3-trials-identify-psychological-and-functional-benefits-of-ambitious-treatment-targets-in-ad (opens in new tab)